Submission Details
| 510(k) Number | K243343 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2024 |
| Decision Date | April 22, 2025 |
| Days to Decision | 179 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K243343 is an FDA 510(k) clearance for the BD CTGCTV2, a Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections (Class II — Special Controls, product code QEP), submitted by Bd Integrated Diagnostic Solutions/Becton, (Sparks, US). The FDA issued a Cleared decision on April 22, 2025, 179 days after receiving the submission on October 25, 2024. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3393.
| 510(k) Number | K243343 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 25, 2024 |
| Decision Date | April 22, 2025 |
| Days to Decision | 179 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QEP — Nucleic Acid Detection System For Non-viral Microorganism(s) Causing Sexually Transmitted Infections |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3393 |
| Definition | A Device To Detect Nucleic Acids From Non-viral Microorganism(s) Causing Sexually Transmitted Infections Is An In Vitro Diagnostic Device Intended For The Detection And Identification Of Nucleic Acids From Non-viral Microorganism(s) In Clinical Specimens Collected From Patients Suspected Of Sexually Transmitted Infections. The Device Is Intended To Aid In The Diagnosis Of Non-viral Sexually Transmitted Infections In Conjunction With Other Clinical And Laboratory Data. |